Page results
-
Labour leader Sir Keir Starmer, who is also the MP for our local constituency, visited UCLH on Friday 3 September and was shown around the Grafton Way Building by our chief executive and chair.
-
Details of the charity and voluntary sector services in Islington and surrounding areas.
-
Professor Karl Peggs was appointed to the Board in August 2024 as the director of research and director of the National Institute for Health and Care Research (NIHR) UCLH Biomedical Research Centre (BRC).
-
Our vaccination centre at the Business Design Centre, Islington, closed on Monday 10 January.
-
More than 400 patients at UCLH have so far benefited from an exciting new cancer treatment called proton beam therapy (PBT) – which uses high-energy beams of protons, rather than X-rays, to deliver a dose of radiotherapy.
-
Sonya Moudart has been appointed as a Mesothelioma UK Clinical Nurse Specialist at UCLH. In her new role, Sonya will provide care and support for mesothelioma (asbestos-related cancer) patients and in time, will be a beacon of expertise in all matters relating to mesothelioma for the North Central London Cancer Alliance area.
-
Rob Vincent joined the board as a non-executive director on 1 November 2021. He was an associate non-executive director from 14 October 2020 to 31 October 2021. Rob lives in Islington. He was the Chief Executive of Kirklees in West Yorkshire until 2010.
-
Geoff Bellingan was appointed Medical Director in September 2009. He previously held posts as Clinical Director and Divisional Clinical Director between 2006 and 2009.
-
Gill was Medical Director for the Specialist Hospitals Board from 2010-2019 and was appointed as medical director, digital healthcare, in October 2019.
-
Tim Hodgson, Consultant in Oral Medicine and Honorary Associate Professor, was appointed Medical Director of the Specialist Hospitals Board UCLH Foundation NHS Trust in November 2019 and joined the Board as an Executive Director in January 2020.
File results
-
FOI/2022/0273 - Proton therapy
-
FOI/2022/0275 - Biologic medications within dermatology
-
FOI/2022/0276 - Biologic medicines within dermatology
-
FOI/2022/0280 - Applications or tools to communicate digitally with patients
-
FOI/2022/0283 - Enhanced disinfection methods to eliminate HAIs in theatres, clinical areas and wards
-
FOI/2022/0302 - Treatment with conditions for rheumatology/ dermatology
-
FOI/2022/0304 - Histopathology labs that run immunohistochemistry diagnostic testing
-
FOI/2022/0326 - Use of temporary, locum or bank staff for Junior Doctors - shifts and spend
-
FOI/2022/0329 - Overseas visitor charges for abortion healthcare
-
FOI/2022/0330 - Sleep and respiratory services